Pfizer has a rich history in vaccine research and development. Today, we are ushering in a new era of vaccine innovation, including investigating a pentavalent meningococcal vaccine, aext-generation vaccine candidate to help protect against pneumococcal disease and a vaccine to help prevent the bacterial infection,Clostridioides difficile.
We are developingmaternal vaccines for diseases, includingrespiratory syncytial virus and Group B streptococcus. If successfully developed and approved, these vaccines would be delivered to mothers during pregnancy to help protect babies when they are infants and most vulnerable.
Combining our expertise in immuno-oncology and vaccines, we are also studying therapeutic vaccine candidates across multiple types of cancer, including prostate cancer.
Share this page
